Trovagene Investor Relations http://trovagene.investorroom.com/ Trovagene Investor Relations Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City http://trovagene.investorroom.com/2017-03-27-Trovagene-to-Present-at-The-MicroCap-Conference-on-April-4-2017-in-New-York-City Mon, 27 Mar 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-03-27-Trovagene-to-Present-at-The-MicroCap-Conference-on-April-4-2017-in-New-York-City Trovagene to Present at the Sidoti & Company Spring 2017 Convention http://trovagene.investorroom.com/2017-03-21-Trovagene-to-Present-at-the-Sidoti-Company-Spring-2017-Convention Tue, 21 Mar 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-03-21-Trovagene-to-Present-at-the-Sidoti-Company-Spring-2017-Convention Trovagene Reports Fourth Quarter and Year End 2016 Financial Results http://trovagene.investorroom.com/2017-03-15-Trovagene-Reports-Fourth-Quarter-and-Year-End-2016-Financial-Results Announces restructuring program to support its expansion into precision cancer therapeutics Wed, 15 Mar 2017 13:04:00 -0700 http://trovagene.investorroom.com/2017-03-15-Trovagene-Reports-Fourth-Quarter-and-Year-End-2016-Financial-Results Trovagene and Nerviano Announce License Agreement for therapeutic candidate PCM-075 http://trovagene.investorroom.com/2017-03-15-Trovagene-and-Nerviano-Announce-License-Agreement-for-therapeutic-candidate-PCM-075 Wed, 15 Mar 2017 13:02:00 -0700 http://trovagene.investorroom.com/2017-03-15-Trovagene-and-Nerviano-Announce-License-Agreement-for-therapeutic-candidate-PCM-075 Trovera™ EGFR Urine Liquid Biopsy Test Predictive of Clinical Response to Therapy: Case Series in Patients with Non-Small Cell Lung Cancer http://trovagene.investorroom.com/2017-03-07-Trovera-TM-EGFR-Urine-Liquid-Biopsy-Test-Predictive-of-Clinical-Response-to-Therapy-Case-Series-in-Patients-with-Non-Small-Cell-Lung-Cancer Authors conclude that ctDNA testing demonstrates clinical utility in assessing disease burden and response to therapy Tue, 07 Mar 2017 05:00:00 -0800 http://trovagene.investorroom.com/2017-03-07-Trovera-TM-EGFR-Urine-Liquid-Biopsy-Test-Predictive-of-Clinical-Response-to-Therapy-Case-Series-in-Patients-with-Non-Small-Cell-Lung-Cancer